PL3680243T3 - Związek pentacykliczny - Google Patents

Związek pentacykliczny

Info

Publication number
PL3680243T3
PL3680243T3 PL18853415T PL18853415T PL3680243T3 PL 3680243 T3 PL3680243 T3 PL 3680243T3 PL 18853415 T PL18853415 T PL 18853415T PL 18853415 T PL18853415 T PL 18853415T PL 3680243 T3 PL3680243 T3 PL 3680243T3
Authority
PL
Poland
Prior art keywords
pentacyclic compound
pentacyclic
compound
Prior art date
Application number
PL18853415T
Other languages
English (en)
Inventor
Yoshiaki Ohashi
Yoshihiko Norimine
Tamaki Hoshikawa
Yu Yoshida
Yoshihisa Kobayashi
Nobuhiro Sato
Koji Hagiwara
Original Assignee
Eisai R&D Management Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co., Ltd. filed Critical Eisai R&D Management Co., Ltd.
Publication of PL3680243T3 publication Critical patent/PL3680243T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL18853415T 2017-09-07 2018-09-05 Związek pentacykliczny PL3680243T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017172169 2017-09-07
PCT/JP2018/032797 WO2019049869A1 (ja) 2017-09-07 2018-09-05 五環式化合物
EP18853415.0A EP3680243B1 (en) 2017-09-07 2018-09-05 Pentacyclic compound

Publications (1)

Publication Number Publication Date
PL3680243T3 true PL3680243T3 (pl) 2022-02-14

Family

ID=65517037

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18853415T PL3680243T3 (pl) 2017-09-07 2018-09-05 Związek pentacykliczny

Country Status (33)

Country Link
US (1) US10239889B1 (pl)
EP (1) EP3680243B1 (pl)
JP (1) JP6557441B1 (pl)
KR (1) KR102307738B1 (pl)
CN (1) CN111051316B (pl)
AR (1) AR112788A1 (pl)
AU (1) AU2018330578B2 (pl)
BR (1) BR112020003197A2 (pl)
CA (1) CA3072740A1 (pl)
CL (1) CL2020000376A1 (pl)
CO (1) CO2020001471A2 (pl)
CY (1) CY1125355T1 (pl)
DK (1) DK3680243T3 (pl)
ES (1) ES2903172T3 (pl)
HR (1) HRP20220019T1 (pl)
HU (1) HUE056791T2 (pl)
IL (1) IL272652B (pl)
JO (1) JOP20200030A1 (pl)
LT (1) LT3680243T (pl)
MA (1) MA50093B1 (pl)
MD (1) MD3680243T2 (pl)
MX (1) MX2020001786A (pl)
PH (1) PH12020500341A1 (pl)
PL (1) PL3680243T3 (pl)
PT (1) PT3680243T (pl)
RS (1) RS62796B1 (pl)
RU (1) RU2754557C1 (pl)
SG (1) SG11202001240XA (pl)
SI (1) SI3680243T1 (pl)
TW (1) TWI707859B (pl)
UA (1) UA125940C2 (pl)
WO (1) WO2019049869A1 (pl)
ZA (1) ZA202000970B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109467538A (zh) 2017-09-07 2019-03-15 和记黄埔医药(上海)有限公司 环烯烃取代的杂芳环类化合物及其用途
AU2018329840A1 (en) 2017-09-07 2020-03-19 Augusta University Research Institute, Inc. Specific Akt3 activator and uses thereof
EP3936189A4 (en) 2019-03-05 2022-12-14 Eisai R&D Management Co., Ltd. SALT OF A PENTACYCLIC COMPOUND AND CRYSTALS THEREOF
AU2020232044A1 (en) 2019-03-05 2021-09-02 Eisai R&D Management Co., Ltd. Pentacyclic heterocyclic compound
EP4069369A4 (en) * 2019-12-06 2024-02-14 Schroedinger Inc CYCLIC COMPOUNDS AND METHODS OF USE THEREOF

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187306A (en) * 1977-07-26 1980-02-05 Bayer Aktiengesellschaft Benzodiazepine-diones, a process for their production and their use as medicaments
DD258234A1 (de) * 1987-03-05 1988-07-13 Univ Leipzig Verfahren zur herstellung von pyrido/3',2':4,5/thieno/2,3-e/imidazo-/1,2-c/pyrimidinen sowie strukturanaloger -pyrimido/1,2-c/pyrimidine bzw. -1,3-diazepino/1,2-c/pyrimidine
RU2117670C1 (ru) * 1988-10-31 1998-08-20 Эйсай Ко., Лтд. Производные триазоло[1,4]диазепина и способы их получения
TW197442B (pl) * 1990-02-08 1993-01-01 Pfizer
KR100203456B1 (ko) * 1995-06-20 1999-06-15 한승수 디하이드로에보디아민-에이치씨1를 유효성분으로 함유하는 알츠하이머병에 의한 치매 치료제
FR2779652B1 (fr) * 1998-06-15 2001-06-08 Sod Conseils Rech Applic Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
JP4751398B2 (ja) * 2004-10-20 2011-08-17 エフ.ホフマン−ラ ロシュ アーゲー ハロゲン置換ベンゾジアゼピン誘導体
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
US8192080B2 (en) 2007-01-23 2012-06-05 Tsi Technologies Llc Microwire-controlled autoclave and method

Also Published As

Publication number Publication date
RU2754557C1 (ru) 2021-09-03
WO2019049869A1 (ja) 2019-03-14
ZA202000970B (en) 2021-07-28
CA3072740A1 (en) 2019-03-14
CO2020001471A2 (es) 2020-05-29
US20190071452A1 (en) 2019-03-07
CN111051316B (zh) 2022-05-31
BR112020003197A2 (pt) 2020-09-29
TWI707859B (zh) 2020-10-21
MA50093A (fr) 2021-05-05
CN111051316A (zh) 2020-04-21
PH12020500341A1 (en) 2020-10-05
TW201920195A (zh) 2019-06-01
EP3680243A1 (en) 2020-07-15
HUE056791T2 (hu) 2022-03-28
AR112788A1 (es) 2019-12-11
CY1125355T1 (el) 2024-02-16
EP3680243B1 (en) 2021-10-27
US10239889B1 (en) 2019-03-26
ES2903172T3 (es) 2022-03-31
RS62796B1 (sr) 2022-02-28
AU2018330578B2 (en) 2022-11-10
KR102307738B1 (ko) 2021-10-05
JP6557441B1 (ja) 2019-08-07
SG11202001240XA (en) 2020-03-30
KR20200051585A (ko) 2020-05-13
IL272652A (en) 2020-03-31
PT3680243T (pt) 2022-01-12
MD3680243T2 (ro) 2022-05-31
AU2018330578A1 (en) 2020-02-27
DK3680243T3 (da) 2022-01-10
HRP20220019T1 (hr) 2022-04-01
EP3680243A4 (en) 2021-01-06
JPWO2019049869A1 (ja) 2019-11-07
MA50093B1 (fr) 2022-05-31
CL2020000376A1 (es) 2020-08-28
IL272652B (en) 2022-09-01
SI3680243T1 (sl) 2022-01-31
LT3680243T (lt) 2021-11-25
UA125940C2 (uk) 2022-07-13
MX2020001786A (es) 2022-09-13
JOP20200030A1 (ar) 2020-02-12

Similar Documents

Publication Publication Date Title
DK3606954T3 (en) Anti-LAG3-antistoffer
IL275044A (en) Aerosolisable structure
DK3499914T3 (en) Høreapparatsystem
DK3615457T3 (en) Transportcontainer
ZA202000970B (en) Pentacyclic compound
GB2569388B (en) Compound
GB2569389B (en) Compound
AU201714106S (en) Mandoline
GB201721179D0 (en) Compound
GB201721178D0 (en) Compound
ZA202001147B (en) Construction component
DK3401557T3 (en) Træskrue
GB201721180D0 (en) Compound
GB201721172D0 (en) Compound
DK3485765T3 (en) Computerbord
GB201617103D0 (en) Compound
DK3704866T3 (en) Datatransmissionssystem
HUE061526T2 (hu) Szerkezet
GB201709565D0 (en) Compound
GB201610497D0 (en) Compound
IL268060B (en) Phenyldifluoromethyl-substituted prolinamide compound
DK3425793T3 (en) Tagsystem
DK3618761T3 (en) Intrakorporalt perfusionssystem
DK3351149T3 (en) Syltetøjsfontæne
GB201721673D0 (en) Compound